{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T01:00:37Z","timestamp":1780275637685,"version":"3.54.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"DOI":"10.1186\/s40644-026-01030-y","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T15:55:34Z","timestamp":1776441334000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Percutaneous ablation of T1b renal tumors: a review"],"prefix":"10.1186","volume":"26","author":[{"given":"Ahmed","family":"Marey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamza","family":"Elkeden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahia","family":"Alrohaibani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Khalaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Karam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surena","family":"Matin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiman","family":"Habibiollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno C.","family":"Odisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Ahrar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed E.","family":"Abdelsalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"1030_CR1","unstructured":"Amin MB, Edge SB, Greene FL, Schilsky RL, Brookland RK, Washington MK, et al. American Joint Committee on Cancer (AJCC). AJCC Cancer Staging Manual. 2017."},{"key":"1030_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/JU.0000000000001911","volume":"206","author":"SC Campbell","year":"2021","unstructured":"Campbell SC, Clark PE, Chang SS, Karam JA, Souter L, Uzzo RG. Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I. J Urol. 2021;206:199\u2013208. https:\/\/doi.org\/10.1097\/JU.0000000000001911.","journal-title":"J Urol"},{"key":"1030_CR3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/J.EURURO.2022.03.006","volume":"82","author":"B Ljungberg","year":"2022","unstructured":"Ljungberg B, Albiges L, Abu-Ghanem Y, Bedke J, Capitanio U, Dabestani S, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. Eur Urol. 2022;82:399\u2013410. https:\/\/doi.org\/10.1016\/J.EURURO.2022.03.006.","journal-title":"Eur Urol"},{"key":"1030_CR4","unstructured":"Kidney cancer - guidelines detail. n.d. https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1440 (accessed February 18, 2026)."},{"key":"1030_CR5","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1111\/J.1464-410X.2008.07718.X","volume":"102","author":"SF Matin","year":"2008","unstructured":"Matin SF, Ahrar K, Wood CG, Daniels M, Jonasch E. Patterns of intervention for renal lesions in von Hippel-Lindau disease. BJU Int. 2008;102:940\u20135. https:\/\/doi.org\/10.1111\/J.1464-410X.2008.07718.X.","journal-title":"BJU Int"},{"key":"1030_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/S00270-016-1531-Y","volume":"40","author":"ME Krokidis","year":"2017","unstructured":"Krokidis ME, Orsi F, Katsanos K, Helmberger T, Adam A. CIRSE Guidelines on Percutaneous Ablation of Small Renal Cell Carcinoma. Cardiovasc Intervent Radiol. 2017;40:177\u201391. https:\/\/doi.org\/10.1007\/S00270-016-1531-Y.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1030_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/J.JVIR.2019.11.004","volume":"31","author":"AJ Gunn","year":"2020","unstructured":"Gunn AJ, Parikh NS, Bhatia S. Society of Interventional Radiology Quality Improvement Standards on Percutaneous Ablation in Renal Cell Carcinoma. J Vasc Interv Radiol. 2020;31:195\u2013e2013. https:\/\/doi.org\/10.1016\/J.JVIR.2019.11.004.","journal-title":"J Vasc Interv Radiol"},{"key":"1030_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/02656736.2019.1605097","volume":"36","author":"BT Welch","year":"2019","unstructured":"Welch BT, Shah PH, Thompson RH, Atwell TD. The current status of thermal ablation in the management of T1b renal masses. Int J Hyperth. 2019;36:31\u20136. https:\/\/doi.org\/10.1080\/02656736.2019.1605097.","journal-title":"Int J Hyperth"},{"key":"1030_CR9","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1080\/02656736.2020.1779356","volume":"37","author":"J Yu","year":"2020","unstructured":"Yu J, Yu XL, Cheng ZG, Hu B, Han ZY, Liu FY, et al. Percutaneous microwave ablation of renal cell carcinoma: practice guidelines of the ultrasound committee of Chinese medical association, interventional oncology committee of Chinese research hospital association. Int J Hyperth. 2020;37:827\u201335. https:\/\/doi.org\/10.1080\/02656736.2020.1779356.","journal-title":"Int J Hyperth"},{"key":"1030_CR10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.21037\/TAU.2017.01.08","volume":"6","author":"AA Schulman","year":"2017","unstructured":"Schulman AA, Tay KJ, Polascik TJ. Expanding thermal ablation to the intermediate-sized renal mass: clinical utility in T1b tumors. Transl Androl Urol. 2017;6:127\u201330. https:\/\/doi.org\/10.21037\/TAU.2017.01.08.","journal-title":"Transl Androl Urol"},{"key":"1030_CR11","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1089\/END.2019.0179","volume":"33","author":"C Palumbo","year":"2019","unstructured":"Palumbo C, Cyr SJ, Mazzone E, Mistretta FA, Knipper S, Pecoraro A, et al. Impact of Tumor Size on Cancer-Specific Mortality Rate After Local Tumor Ablation in T1a Renal-Cell Carcinoma. J Endourol. 2019;33:606\u201313. https:\/\/doi.org\/10.1089\/END.2019.0179.","journal-title":"J Endourol"},{"key":"1030_CR12","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.eururo.2011.06.040","volume":"60","author":"H Van Poppel","year":"2011","unstructured":"Van Poppel H, Becker F, Cadeddu JA, Gill IS, Janetschek G, Jewett MAS, et al. Treatment of localised renal cell carcinoma. Eur Urol. 2011;60:662\u201372. https:\/\/doi.org\/10.1016\/j.eururo.2011.06.040.","journal-title":"Eur Urol"},{"key":"1030_CR13","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1148\/RADIOL.2016161225","volume":"283","author":"AWP Maxwell","year":"2017","unstructured":"Maxwell AWP, Baird GL, Iannuccilli JD, Mayo-Smith WW, Dupuy DE. Renal Cell Carcinoma: Comparison of RENAL Nephrometry and PADUA Scores with Maximum Tumor Diameter for Prediction of Local Recurrence after Thermal Ablation. Radiology. 2017;283:590\u20137. https:\/\/doi.org\/10.1148\/RADIOL.2016161225.","journal-title":"Radiology"},{"key":"1030_CR14","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00270-020-02423-7","volume":"43","author":"BM Aarts","year":"2020","unstructured":"Aarts BM, Prevoo W, Meier MAJ, Bex A, Beets-Tan RGH, Klompenhouwer EG, et al. Percutaneous Microwave Ablation of Histologically Proven T1 Renal Cell Carcinoma. Cardiovasc Intervent Radiol. 2020;43:1025\u201333. https:\/\/doi.org\/10.1007\/s00270-020-02423-7.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1030_CR15","doi-asserted-by":"publisher","unstructured":"Ierardi AM, Puliti A, Angileri SA, Petrillo M, Duka E, Floridi C, et al. Microwave ablation of malignant renal tumours: intermediate-term results and usefulness of RENAL and mRENAL scores for predicting outcomes and complications. Medical Oncology 2017;34. https:\/\/doi.org\/10.1007\/s12032-017-0948-8.","DOI":"10.1007\/s12032-017-0948-8"},{"key":"1030_CR16","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1148\/RG.2019190083","volume":"39","author":"MA Lum","year":"2019","unstructured":"Lum MA, Shah SB, Durack JC, Nikolovski I. Imaging of small renal masses before and after thermal ablation. Radiographics. 2019;39:2134\u201345. https:\/\/doi.org\/10.1148\/RG.2019190083.","journal-title":"Radiographics"},{"key":"1030_CR17","doi-asserted-by":"publisher","unstructured":"Abdelsalam ME, Ahrar K. Ablation of small renal masses. Tech Vasc Interv Radiol 2020;23. https:\/\/doi.org\/10.1016\/j.tvir.2020.100674.","DOI":"10.1016\/j.tvir.2020.100674"},{"key":"1030_CR18","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.2214\/AJR.09.2582","volume":"192","author":"RN Uppot","year":"2009","unstructured":"Uppot RN, Silverman SG, Zagoria RJ, Tuncali K, Childs DD, Gervais DA. Imaging-guided percutaneous ablation of renal cell carcinoma: a primer of how we do it. AJR Am J Roentgenol. 2009;192:1558\u201370. https:\/\/doi.org\/10.2214\/AJR.09.2582.","journal-title":"AJR Am J Roentgenol"},{"key":"1030_CR19","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00345-014-1284-7","volume":"32","author":"T Klatte","year":"2014","unstructured":"Klatte T, Kroeger N, Zimmermann U, Burchardt M, Belldegrun AS, Pantuck AJ. The contemporary role of ablative treatment approaches in the management of renal cell carcinoma (RCC): Focus on radiofrequency ablation (RFA), high-intensity focused ultrasound (HIFU), and cryoablation. World J Urol. 2014;32:597\u2013605. https:\/\/doi.org\/10.1007\/s00345-014-1284-7.","journal-title":"World J Urol"},{"key":"1030_CR20","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1089\/end.2013.0192","volume":"27","author":"YS Tanagho","year":"2013","unstructured":"Tanagho YS, Bhayani SB, Kim EH, Figenshau RS. Renal cryoablation versus robot-assisted partial nephrectomy: Washington University long-term experience. J Endourol. 2013;27:1477\u201386. https:\/\/doi.org\/10.1089\/end.2013.0192.","journal-title":"J Endourol"},{"key":"1030_CR21","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1016\/J.JVIR.2008.06.006","volume":"19","author":"TM Wah","year":"2008","unstructured":"Wah TM, Irving HC. Infectious complications after percutaneous radiofrequency ablation of renal cell carcinoma in patients with ileal conduit. J Vasc Interv Radiol. 2008;19:1382\u20135. https:\/\/doi.org\/10.1016\/J.JVIR.2008.06.006.","journal-title":"J Vasc Interv Radiol"},{"key":"1030_CR22","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/J.EURURO.2007.03.063","volume":"52","author":"NI Fotiadis","year":"2007","unstructured":"Fotiadis NI, Sabharwal T, Morales JP, Hodgson DJ, O\u2019Brien TS, Adam A. Combined percutaneous radiofrequency ablation and ethanol injection of renal tumours: midterm results. Eur Urol. 2007;52:777\u201384. https:\/\/doi.org\/10.1016\/J.EURURO.2007.03.063.","journal-title":"Eur Urol"},{"key":"1030_CR23","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1007\/S00330-013-2802-5","volume":"23","author":"M Krokidis","year":"2013","unstructured":"Krokidis M, Spiliopoulos S, Jarzabek M, Fotiadis N, Sabharwal T, O\u2019Brien T, et al. Percutaneous radiofrequency ablation of small renal tumours in patients with a single functioning kidney: long-term results. Eur Radiol. 2013;23:1933\u20139. https:\/\/doi.org\/10.1007\/S00330-013-2802-5.","journal-title":"Eur Radiol"},{"key":"1030_CR24","doi-asserted-by":"publisher","first-page":"802437","DOI":"10.3389\/fonc.2022.802437","volume":"12","author":"H Shi","year":"2022","unstructured":"Shi H, Li J, Fan Z, Yang J, Fu S, Wang H, et al. Comparison of Radiofrequency Ablation Versus Cryoablation For T1 Renal Tumors: An Evidence-Based Analysis of Comparative Outcomes. Front Oncol. 2022;12:802437. https:\/\/doi.org\/10.3389\/fonc.2022.802437.","journal-title":"Front Oncol"},{"key":"1030_CR25","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.2214\/AJR.06.1152","volume":"188","author":"TD Atwell","year":"2007","unstructured":"Atwell TD, Farrell MA, Callstrom MR, Charboneau JW, Leibovich BC, Frank I, et al. Percutaneous cryoablation of large renal masses: technical feasibility and short-term outcome. AJR Am J Roentgenol. 2007;188:1195\u2013200. https:\/\/doi.org\/10.2214\/AJR.06.1152.","journal-title":"AJR Am J Roentgenol"},{"key":"1030_CR26","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2214\/AJR.07.2258","volume":"189","author":"RJ Zagoria","year":"2007","unstructured":"Zagoria RJ, Traver MA, Werle DM, Perini M, Hayasaka S, Clark PE. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am J Roentgenol. 2007;189:429\u201336. https:\/\/doi.org\/10.2214\/AJR.07.2258.","journal-title":"AJR Am J Roentgenol"},{"key":"1030_CR27","first-page":"359","volume":"48","author":"SN Goldberg","year":"2001","unstructured":"Goldberg SN, Gazelle GS. Radiofrequency tissue ablation: physical principles and techniques for increasing coagulation necrosis. Hepatogastroenterology. 2001;48:359\u201367.","journal-title":"Hepatogastroenterology"},{"key":"1030_CR28","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1097\/01.ju.0000119905.72574.de","volume":"171","author":"JJ Hwang","year":"2004","unstructured":"Hwang JJ, Walther MM, Pautler SE, Coleman JA, Hvizda J, Peterson J, et al. Radio frequency ablation of small renal tumors: Intermediate results. J Urol. 2004;171:1814\u20138. https:\/\/doi.org\/10.1097\/01.ju.0000119905.72574.de.","journal-title":"J Urol"},{"key":"1030_CR29","doi-asserted-by":"publisher","unstructured":"Seager M, Kumar S, Lim E, Munneke G, Bandula S, Walkden M. Renal cryoablation \u2013 a practical guide for interventional radiologists. Br J Radiol. 2021;94. https:\/\/doi.org\/10.1259\/bjr.20200854.","DOI":"10.1259\/bjr.20200854"},{"key":"1030_CR30","doi-asserted-by":"publisher","unstructured":"Cooper IS. Cryogenic surgery. 2010;268:743\u20139. https:\/\/doi.org\/10.1056\/NEJM196304042681401.","DOI":"10.1056\/NEJM196304042681401"},{"key":"1030_CR31","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/S0022-5347(01)63618-8","volume":"159","author":"SG Chosy","year":"1998","unstructured":"Chosy SG, Nakada SY, Lee FT, Warner TF, MONITORING RENAL CRYOSURGERY. PREDICTORS OF TISSUE NECROSIS IN SWINE. J Urol. 1998;159:1370\u20134. https:\/\/doi.org\/10.1016\/S0022-5347(01)63618-8.","journal-title":"J Urol"},{"key":"1030_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0090-4295(98)00169-1","volume":"52","author":"SC Campbell","year":"1998","unstructured":"Campbell SC, Krishnamurthi V, Chow G, Hale J, Myles J, Novick AC. Renal cryosurgery: Experimental evaluation of treatment parameters. Urology. 1998;52:29\u201334. https:\/\/doi.org\/10.1016\/S0090-4295(98)00169-1.","journal-title":"Urology"},{"key":"1030_CR33","doi-asserted-by":"publisher","first-page":"S192","DOI":"10.1016\/j.jvir.2010.04.007","volume":"21","author":"MG Lubner","year":"2010","unstructured":"Lubner MG, Brace CL, Hinshaw JL, Lee FT. Microwave tumor ablation: Mechanism of action, clinical results, and devices. J Vasc Interv Radiol. 2010;21:S192\u2013203. https:\/\/doi.org\/10.1016\/j.jvir.2010.04.007.","journal-title":"J Vasc Interv Radiol"},{"key":"1030_CR34","doi-asserted-by":"publisher","unstructured":"Simon CJ, Dupuy DE, Mayo-Smith WW. Microwave ablation: principles and applications1. 2005;25. https:\/\/doi.org\/10.1148\/RG.25SI055501.","DOI":"10.1148\/RG.25SI055501"},{"key":"1030_CR35","doi-asserted-by":"publisher","DOI":"10.1148\/RADIOL.12111209","author":"J Yu","year":"2012","unstructured":"Yu J, Liang P, Yu XL, Cheng ZG, Han ZY, Mu MJ, et al. US-guided percutaneous microwave ablation of renal cell carcinoma: intermediate-term results. 2012;263:900\u20138. https:\/\/doi.org\/10.1148\/RADIOL.12111209."},{"key":"1030_CR36","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S0022-5347(05)00247-8","volume":"175","author":"A Gupta","year":"2006","unstructured":"Gupta A, Allaf ME, Kavoussi LR, Jarrett TW, Chan DYS, Su LM, et al. Computerized Tomography Guided Percutaneous Renal Cryoablation With the Patient Under Conscious Sedation: Initial Clinical Experience. J Urol. 2006;175:447\u201353. https:\/\/doi.org\/10.1016\/S0022-5347(05)00247-8.","journal-title":"J Urol"},{"key":"1030_CR37","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1053\/J.TVIR.2013.08.006","volume":"16","author":"C Georgiades","year":"2013","unstructured":"Georgiades C, Rodriguez R. Renal tumor ablation. Tech Vasc Interv Radiol. 2013;16:230\u20138. https:\/\/doi.org\/10.1053\/J.TVIR.2013.08.006.","journal-title":"Tech Vasc Interv Radiol"},{"key":"1030_CR38","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1007\/S00330-004-2413-2","volume":"14","author":"A Veltri","year":"2004","unstructured":"Veltri A, De Fazio G, Malfitana V, Isolato G, Fontana D, Tizzani A, et al. Percutaneous US-guided RF thermal ablation for malignant renal tumors: preliminary results in 13 patients. Eur Radiol. 2004;14:2303\u201310. https:\/\/doi.org\/10.1007\/S00330-004-2413-2.","journal-title":"Eur Radiol"},{"key":"1030_CR39","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/J.EJRAD.2009.03.050","volume":"75","author":"BK Park","year":"2010","unstructured":"Park BK, Kim CK, Choi HY, Lee HM, Jeon SS, Seo S, Il, et al. Limitation for performing ultrasound-guided radiofrequency ablation of small renal masses. Eur J Radiol. 2010;75:248\u201352. https:\/\/doi.org\/10.1016\/J.EJRAD.2009.03.050.","journal-title":"Eur J Radiol"},{"key":"1030_CR40","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1089\/END.2008.0232","volume":"23","author":"WJ Badger","year":"2009","unstructured":"Badger WJ, De Araujo HAM, Kuehn DM, Angresen KJ, Winfield HN. Laparoscopic renal tumor cryoablation: appropriate application of real-time ultrasonographic monitoring. J Endourol. 2009;23:427\u201330. https:\/\/doi.org\/10.1089\/END.2008.0232.","journal-title":"J Endourol"},{"key":"1030_CR41","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1148\/RADIOL.2323021351","volume":"232","author":"JS Lewin","year":"2004","unstructured":"Lewin JS, Nour SG, Connell CF, Sulman A, Duerk JL, Resnick MI, et al. Phase II clinical trial of interactive MR imaging-guided interstitial radiofrequency thermal ablation of primary kidney tumors: initial experience. Radiology. 2004;232:835\u201345. https:\/\/doi.org\/10.1148\/RADIOL.2323021351.","journal-title":"Radiology"},{"key":"1030_CR42","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1148\/RADIOL.2362041107","volume":"236","author":"SG Silverman","year":"2005","unstructured":"Silverman SG, Tuncali K, VanSonnenberg E, Morrison PR, Shankar S, Ramaiya N, et al. Renal tumors: MR imaging-guided percutaneous cryotherapy\u2013initial experience in 23 patients. Radiology. 2005;236:716\u201324. https:\/\/doi.org\/10.1148\/RADIOL.2362041107.","journal-title":"Radiology"},{"key":"1030_CR43","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/J.JVIR.2007.08.026","volume":"18","author":"BK Park","year":"2007","unstructured":"Park BK, Kim SH, Byun JY, Kim YS, Kwon GY, Jang IS. CT-guided instillation of 5% dextrose in water into the anterior pararenal space before renal radiofrequency ablation in a porcine model: positive and negative effects. J Vasc Interv Radiol. 2007;18:1561\u20139. https:\/\/doi.org\/10.1016\/J.JVIR.2007.08.026.","journal-title":"J Vasc Interv Radiol"},{"key":"1030_CR44","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1097\/01.RVI.0000133535.16753.58","volume":"15","author":"AW Kam","year":"2004","unstructured":"Kam AW, Littrup PJ, Walther MM, Hvizda J, Wood BJ. Thermal protection during percutaneous thermal ablation of renal cell carcinoma. J Vasc Interv Radiol. 2004;15:753\u20138. https:\/\/doi.org\/10.1097\/01.RVI.0000133535.16753.58.","journal-title":"J Vasc Interv Radiol"},{"key":"1030_CR45","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1097\/01.RVI.0000175322.05225.0A","volume":"16","author":"TM Wah","year":"2005","unstructured":"Wah TM, Koenig P, Irving HC, Gervais DA, Mueller PR. Radiofrequency ablation of a central renal tumor: protection of the collecting system with a retrograde cold dextrose pyeloperfusion technique. J Vasc Interv Radiol. 2005;16:1551\u20135. https:\/\/doi.org\/10.1097\/01.RVI.0000175322.05225.0A.","journal-title":"J Vasc Interv Radiol"},{"key":"1030_CR46","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/J.JVIR.2008.04.005","volume":"19","author":"CP Cantwell","year":"2008","unstructured":"Cantwell CP, Wah TM, Gervais DA, Eisner BH, Arellano R, Uppot RN, et al. Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of retrograde pyeloperfusion with cooled dextrose 5% in water. J Vasc Interv Radiol. 2008;19:1034\u201340. https:\/\/doi.org\/10.1016\/J.JVIR.2008.04.005.","journal-title":"J Vasc Interv Radiol"},{"key":"1030_CR47","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/J.JVIR.2009.09.014","volume":"21","author":"A Froemming","year":"2010","unstructured":"Froemming A, Atwell T, Farrell M, Callstrom M, Leibovich B, Charboneau W. Probe retraction during renal tumor cryoablation: a technique to minimize direct ureteral injury. J Vasc Interv Radiol. 2010;21:148\u201351. https:\/\/doi.org\/10.1016\/J.JVIR.2009.09.014.","journal-title":"J Vasc Interv Radiol"},{"key":"1030_CR48","doi-asserted-by":"publisher","first-page":"86","DOI":"10.2214\/AJR.185.1.01850086","volume":"185","author":"K Ahrar","year":"2005","unstructured":"Ahrar K, Matin S, Wallace MJ, Gupta S, Hicks ME. Percutaneous transthoracic radiofrequency ablation of renal tumors using an iatrogenic pneumothorax. AJR Am J Roentgenol. 2005;185:86\u20138. https:\/\/doi.org\/10.2214\/AJR.185.1.01850086.","journal-title":"AJR Am J Roentgenol"},{"key":"1030_CR49","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1055\/S-2001-18309","volume":"173","author":"J Tacke","year":"2001","unstructured":"Tacke J, Mahnken A, B\u00fccke A, Rohde D, Gunther RW. Nephron-sparing percutaneous ablation of a 5\u00a0cm renal cell carcinoma by superselective embolization and percutaneous RF-ablation. Rofo. 2001;173:980\u20133. https:\/\/doi.org\/10.1055\/S-2001-18309.","journal-title":"Rofo"},{"key":"1030_CR50","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jvir.2015.02.010","volume":"26","author":"TD Atwell","year":"2015","unstructured":"Atwell TD, Vlaminck JJ, Boorjian SA, Kurup AN, Callstrom MR, Weisbrod AJ, et al. Percutaneous cryoablation of stage T1b renal cell carcinoma: Technique considerations, safety, and local tumor control. J Vasc Interv Radiol. 2015;26:792\u20139. https:\/\/doi.org\/10.1016\/j.jvir.2015.02.010.","journal-title":"J Vasc Interv Radiol"},{"key":"1030_CR51","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/J.EJRAD.2016.10.024","volume":"86","author":"CM Sommer","year":"2017","unstructured":"Sommer CM, Pallwein-Prettner L, Vollherbst DF, Seidel R, Rieder C, Radeleff BA, et al. Transarterial embolization (TAE) as add-on to percutaneous radiofrequency ablation (RFA) for the treatment of renal tumors: Review of the literature, overview of state-of-the-art embolization materials and further perspective of advanced image-guided tumor ablation. Eur J Radiol. 2017;86:143\u201362. https:\/\/doi.org\/10.1016\/J.EJRAD.2016.10.024.","journal-title":"Eur J Radiol"},{"key":"1030_CR52","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2214\/AJR.185.1.01850064","volume":"185","author":"DA Gervais","year":"2005","unstructured":"Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol. 2005;185:64\u201371. https:\/\/doi.org\/10.2214\/AJR.185.1.01850064.","journal-title":"AJR Am J Roentgenol"},{"key":"1030_CR53","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1007\/s00270-019-02226-5","volume":"42","author":"AJ Gunn","year":"2019","unstructured":"Gunn AJ, Joe WB, Salei A, El Khudari H, Mahmoud KH, Bready E, et al. Percutaneous Cryoablation of Stage T1b Renal Cell Carcinoma: Safety, Technical Results, and Clinical Outcomes. Cardiovasc Intervent Radiol. 2019;42:970\u20138. https:\/\/doi.org\/10.1007\/s00270-019-02226-5.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1030_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/J.UROLONC.2022.11.025","author":"K Aikawa","year":"2023","unstructured":"Aikawa K, Yanagisawa T, Fukuokaya W, Shimizu K, Miyajima K, Nakazono M, et al. Percutaneous cryoablation versus partial nephrectomy for cT1b renal tumors: An inverse probability weight analysis. Urologic Oncology: Seminars Original Investigations. 2023. https:\/\/doi.org\/10.1016\/J.UROLONC.2022.11.025.","journal-title":"Urologic Oncology: Seminars Original Investigations"},{"key":"1030_CR55","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1080\/02656736.2019.1675913","volume":"36","author":"R Grange","year":"2019","unstructured":"Grange R, Tradi F, Izaaryene J, Daidj N, Brunelle S, Walz J, et al. Computed tomography-guided percutaneous cryoablation of T1b renal tumors: safety, functional and oncological outcomes. Int J Hyperth. 2019;36:1065\u201371. https:\/\/doi.org\/10.1080\/02656736.2019.1675913.","journal-title":"Int J Hyperth"},{"key":"1030_CR56","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1159\/000447218","volume":"11","author":"D Curry","year":"2018","unstructured":"Curry D, Pahuja A, Loan W, Thwaini A. Radiofrequency Ablation of Small Renal Masses: Outcomes, Complications and Effects on Renal Function. Curr Urol. 2018;11:196\u2013200. https:\/\/doi.org\/10.1159\/000447218.","journal-title":"Curr Urol"},{"key":"1030_CR57","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/S00270-017-1820-0","volume":"41","author":"S Hebbadj","year":"2018","unstructured":"Hebbadj S, Cazzato RL, Garnon J, Shaygi B, Buy X, Tsoumakidou G, et al. Safety Considerations and Local Tumor Control Following Percutaneous Image-Guided Cryoablation of T1b Renal Tumors. Cardiovasc Intervent Radiol. 2018;41:449\u201358. https:\/\/doi.org\/10.1007\/S00270-017-1820-0.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1030_CR58","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/S11604-018-0756-X","volume":"36","author":"T Hasegawa","year":"2018","unstructured":"Hasegawa T, Yamanaka T, Gobara H, Miyazaki M, Takaki H, Sato Y, et al. Radiofrequency ablation versus cryoablation for T1b renal cell carcinoma: a multi-center study. Jpn J Radiol. 2018;36:551\u20138. https:\/\/doi.org\/10.1007\/S11604-018-0756-X.","journal-title":"Jpn J Radiol"},{"key":"1030_CR59","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1007\/S00261-020-02662-9","volume":"45","author":"KA Wetley","year":"2020","unstructured":"Wetley KA, Abel EJ, Dreyfuss LD, Huang W, Brace CL, Wells SA. CT and MR imaging surveillance of stage 1 renal cell carcinoma after microwave ablation. Abdom Radiol (NY). 2020;45:2810\u201324. https:\/\/doi.org\/10.1007\/S00261-020-02662-9.","journal-title":"Abdom Radiol (NY)"},{"key":"1030_CR60","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00330-021-07900-2","volume":"32","author":"J Yu","year":"2022","unstructured":"Yu J, Wang H, Cheng ZG, Liu FY, Li Qying, He G, zhi, et al. A multicenter 10-year oncologic outcome of ultrasound-guided percutaneous microwave ablation of clinical T1 renal cell carcinoma: will it stand the test of time? Eur Radiol. 2022;32:89\u2013100. https:\/\/doi.org\/10.1007\/s00330-021-07900-2.","journal-title":"Eur Radiol"},{"key":"1030_CR61","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1089\/END.2020.0382","volume":"34","author":"J Guo","year":"2020","unstructured":"Guo J, Arellano RS. Percutaneous Microwave Ablation of Stage T1b Renal Cell Carcinoma: Short-Term Assessment of Technical Feasibility, Short-Term Oncologic Outcomes, and Safety. J Endourol. 2020;34:1021\u20137. https:\/\/doi.org\/10.1089\/END.2020.0382.","journal-title":"J Endourol"},{"key":"1030_CR62","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.urology.2019.09.024","volume":"135","author":"DD Shapiro","year":"2020","unstructured":"Shapiro DD, Wells SA, Best SL, Hedican SP, Ziemlewicz TJ, Lubner MG, et al. Comparing Outcomes for Patients with Clinical T1b Renal Cell Carcinoma Treated With Either Percutaneous Microwave Ablation or Surgery. Urology. 2020;135:88\u201394. https:\/\/doi.org\/10.1016\/j.urology.2019.09.024.","journal-title":"Urology"},{"key":"1030_CR63","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1080\/02656736.2017.1408147","volume":"34","author":"DK Filippiadis","year":"2018","unstructured":"Filippiadis DK, Gkizas C, Chrysofos M, Siatelis A, Velonakis G, Alexopoulou E, et al. Percutaneous microwave ablation of renal cell carcinoma using a high power microwave system: focus upon safety and efficacy. Int J Hyperth. 2018;34:1077\u201381. https:\/\/doi.org\/10.1080\/02656736.2017.1408147.","journal-title":"Int J Hyperth"},{"key":"1030_CR64","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s00261-016-0776-x","volume":"41","author":"SA Wells","year":"2016","unstructured":"Wells SA, Wheeler KM, Mithqal A, Patel MS, Brace CL, Schenkman NS. Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment. Abdom Radiol. 2016;41:1203\u201311. https:\/\/doi.org\/10.1007\/s00261-016-0776-x.","journal-title":"Abdom Radiol"},{"key":"1030_CR65","doi-asserted-by":"publisher","unstructured":"Efthymiou E, Siatelis A, Liakouras C, Makris G, Chrisofos M, Kelekis A, et al. Computed tomography-guided percutaneous microwave ablation for renal cell carcinoma: impact of tumor size on the progression survival rates. Diagnostics (Basel). 2021;11. https:\/\/doi.org\/10.3390\/diagnostics11091618.","DOI":"10.3390\/diagnostics11091618"},{"key":"1030_CR66","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/bju.15224","volume":"127","author":"JB John","year":"2021","unstructured":"John JB, Anderson M, Dutton T, Stott M, Crundwell M, Llewelyn R, et al. Percutaneous microwave ablation of renal masses in a UK cohort. BJU Int. 2021;127:486\u201394. https:\/\/doi.org\/10.1111\/bju.15224.","journal-title":"BJU Int"},{"key":"1030_CR67","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1080\/02656736.2021.1970826","volume":"38","author":"G Cazalas","year":"2021","unstructured":"Cazalas G, Jambon E, Coussy A, Le Bras Y, Petitpierre F, Berhnard JC, et al. Local recurrence and other oncologic outcomes after percutaneous image-guided tumor ablations on stageT1b renal cell carcinoma: a systematic review and network meta-analysis. Int J Hyperth. 2021;38:1295\u2013303. https:\/\/doi.org\/10.1080\/02656736.2021.1970826.","journal-title":"Int J Hyperth"},{"key":"1030_CR68","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.eururo.2016.08.039","volume":"71","author":"PA Caputo","year":"2017","unstructured":"Caputo PA, Zargar H, Ramirez D, Andrade HS, Akca O, Gao T, et al. Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis. Eur Urol. 2017;71:111\u20137. https:\/\/doi.org\/10.1016\/j.eururo.2016.08.039.","journal-title":"Eur Urol"},{"key":"1030_CR69","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/J.JVIR.2017.08.013","volume":"29","author":"JR Rivero","year":"2018","unstructured":"Rivero JR, De La Cerda J, Wang H, Liss MA, Farrell AM, Rodriguez R, et al. Partial Nephrectomy versus Thermal Ablation for Clinical Stage T1 Renal Masses: Systematic Review and Meta-Analysis of More than 3,900 Patients. J Vasc Interv Radiol. 2018;29:18\u201329. https:\/\/doi.org\/10.1016\/J.JVIR.2017.08.013.","journal-title":"J Vasc Interv Radiol"},{"key":"1030_CR70","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/S00270-014-0846-9","volume":"37","author":"K Katsanos","year":"2014","unstructured":"Katsanos K, Mailli L, Krokidis M, McGrath A, Sabharwal T, Adam A. Systematic review and meta-analysis of thermal ablation versus surgical nephrectomy for small renal tumours. Cardiovasc Intervent Radiol. 2014;37:427\u201337. https:\/\/doi.org\/10.1007\/S00270-014-0846-9.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1030_CR71","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/J.UROLONC.2022.04.002","volume":"40","author":"T Yanagisawa","year":"2022","unstructured":"Yanagisawa T, Mori K, Kawada T, Motlagh RS, Mostafaei H, Quhal F, et al. Differential efficacy of ablation therapy versus partial nephrectomy between clinical T1a and T1b renal tumors: A systematic review and meta-analysis. Urol Oncol. 2022;40:315\u201330. https:\/\/doi.org\/10.1016\/J.UROLONC.2022.04.002.","journal-title":"Urol Oncol"},{"key":"1030_CR72","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/J.JVIR.2022.07.007","volume":"33","author":"T Junker","year":"2022","unstructured":"Junker T, Duus L, Rasmussen BSB, Azawi N, Lund L, N\u00f8rgaard B, et al. Partial Nephrectomy versus Percutaneous Cryoablation of Small Renal Cell Carcinomas: A Comparison of Adverse Events in a Prospective Multicenter Cohort Study. J Vasc Interv Radiol. 2022;33:1375\u2013e13837. https:\/\/doi.org\/10.1016\/J.JVIR.2022.07.007.","journal-title":"J Vasc Interv Radiol"},{"key":"1030_CR73","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1055\/s-0033-1363842","volume":"31","author":"AN Kurup","year":"2014","unstructured":"Kurup AN. Percutaneous ablation for small renal masses-Complications. Semin Intervent Radiol. 2014;31:42\u20139. https:\/\/doi.org\/10.1055\/s-0033-1363842.","journal-title":"Semin Intervent Radiol"},{"key":"1030_CR74","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.urology.2019.08.022","volume":"134","author":"LD Dreyfuss","year":"2019","unstructured":"Dreyfuss LD, Wells SA, Best SL, Hedican SP, Ziemlewicz TJ, Lubner MG, et al. Development of a Risk-stratified Approach for Follow-up Imaging After Percutaneous Thermal Ablation of Sporadic Stage One Renal Cell Carcinoma. Urology. 2019;134:148\u201353. https:\/\/doi.org\/10.1016\/j.urology.2019.08.022.","journal-title":"Urology"},{"key":"1030_CR75","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/J.EUF.2021.02.007","volume":"8","author":"M Brassier","year":"2022","unstructured":"Brassier M, Khene ZE, Bernhard JC, Dang VT, Ouzaid I, Nouhaud FX, et al. Percutaneous Ablation Versus Surgical Resection for Local Recurrence Following Partial Nephrectomy for Renal Cell Cancer: A Propensity Score Analysis (REPART Study-UroCCR 71). Eur Urol Focus. 2022;8:210\u20136. https:\/\/doi.org\/10.1016\/J.EUF.2021.02.007.","journal-title":"Eur Urol Focus"},{"key":"1030_CR76","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1007\/S00270-022-03079-1","volume":"45","author":"J Rossi","year":"2022","unstructured":"Rossi J, Cazzato RL, de Marini P, Auloge P, Autrusseau PA, Dalili D, et al. Safety and Oncologic Outcomes of Percutaneous Cryoablation of Renal Cell Carcinoma Recurrences in the Ipsilateral Kidney Following Partial Nephrectomy. Cardiovasc Intervent Radiol. 2022;45:656\u201364. https:\/\/doi.org\/10.1007\/S00270-022-03079-1.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1030_CR77","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1007\/s11604-021-01168-8","volume":"39","author":"K Shimizu","year":"2021","unstructured":"Shimizu K, Enoki K, Kameoka Y, Motohashi K, Yanagisawa T, Miki J, et al. Image-guided percutaneous cryoablation of T1b renal cell carcinomas in patients with comorbidities. Jpn J Radiol. 2021;39:1213\u201322. https:\/\/doi.org\/10.1007\/s11604-021-01168-8.","journal-title":"Jpn J Radiol"},{"key":"1030_CR78","doi-asserted-by":"publisher","DOI":"10.1177\/02841851221081825","author":"LA Duus","year":"2022","unstructured":"Duus LA, Junker T, Rasmussen BS, Bojsen JA, Pedersen AL, Anthonsen A, et al. Safety, efficacy, and mid-term oncological outcomes of computed tomography-guided cryoablation of T1 renal cancer. Acta Radiol. 2022. https:\/\/doi.org\/10.1177\/02841851221081825.","journal-title":"Acta Radiol"},{"key":"1030_CR79","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.eururo.2014.07.021","volume":"67","author":"RH Thompson","year":"2015","unstructured":"Thompson RH, Atwell T, Schmit G, Lohse CM, Kurup AN, Weisbrod A, et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol. 2015;67:252\u20139. https:\/\/doi.org\/10.1016\/j.eururo.2014.07.021.","journal-title":"Eur Urol"},{"key":"1030_CR80","doi-asserted-by":"publisher","unstructured":"Liu H-Y, Kang CH, Wang H-J, Chen CH, Luo HL, Chen Y-T, et al. Comparison of robot-assisted laparoscopic partial nephrectomy with laparoscopic cryoablation in the treatment of localised renal tumours: a propensity score-matched comparison of long-term outcomes. Diagnostics (Basel). 2021;11. https:\/\/doi.org\/10.3390\/diagnostics11050759.","DOI":"10.3390\/diagnostics11050759"},{"key":"1030_CR81","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.eururo.2009.11.025","volume":"57","author":"JL del Cura","year":"2010","unstructured":"del Cura JL, Zabala R, Iriarte JI, Unda M. Treatment of Renal Tumors by Percutaneous Ultrasound-Guided Radiofrequency Ablation Using a Multitined Electrode: Effectiveness and Complications. Eur Urol. 2010;57:459\u201365. https:\/\/doi.org\/10.1016\/j.eururo.2009.11.025.","journal-title":"Eur Urol"},{"key":"1030_CR82","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1148\/radiol.13130221","volume":"270","author":"H Takaki","year":"2014","unstructured":"Takaki H, Soga N, Kanda H, Nakatsuka A, Uraki J, Fujimori M, et al. Radiofrequency ablation versus radical nephrectomy: Clinical outcomes for stage T1b renal cell carcinoma. Radiology. 2014;270:292\u20139. https:\/\/doi.org\/10.1148\/radiol.13130221.","journal-title":"Radiology"},{"key":"1030_CR83","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/J.JURO.2014.07.112","volume":"193","author":"X Chang","year":"2015","unstructured":"Chang X, Zhang F, Liu T, Ji C, Zhao X, Yang R, et al. Radio frequency ablation versus partial nephrectomy for clinical T1b renal cell carcinoma: Long-term clinical and oncologic outcomes. J Urol. 2015;193:430\u20135. https:\/\/doi.org\/10.1016\/J.JURO.2014.07.112.","journal-title":"J Urol"},{"key":"1030_CR84","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1177\/0284185118780891","volume":"60","author":"V Acosta Ruiz","year":"2019","unstructured":"Acosta Ruiz V, Ladjevardi S, Brekkan E, H\u00e4ggman M, L\u00f6nnemark M, Wernroth L, et al. Periprocedural outcome after laparoscopic partial nephrectomy versus radiofrequency ablation for T1 renal tumors: a modified R.E.N.A.L nephrometry score adjusted comparison. Acta Radiol. 2019;60:260\u20138. https:\/\/doi.org\/10.1177\/0284185118780891.","journal-title":"Acta Radiol"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40644-026-01030-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-026-01030-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-026-01030-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:02:35Z","timestamp":1780272155000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40644-026-01030-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1030"],"URL":"https:\/\/doi.org\/10.1186\/s40644-026-01030-y","relation":{"references":[{"id-type":"doi","id":"10.1148\/RADIOL.12111209","asserted-by":"subject"}]},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"31 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"72"}}